Nick Hellmann, MD EVP, Medical and Scientific Affairs

16
1 Building on the Zimbabwe Experience to Achieve Global Elimination of New HIV Infections in Children Nick Hellmann, MD EVP, Medical and Scientific Affairs

description

Building on the Zimbabwe Experience to Achieve Global Elimination of New HIV Infections in Children. Nick Hellmann, MD EVP, Medical and Scientific Affairs. Global Impact of HIV/AIDS on Children. Together We Will End AIDS (UNAIDS, July 2012). - PowerPoint PPT Presentation

Transcript of Nick Hellmann, MD EVP, Medical and Scientific Affairs

Page 1: Nick Hellmann, MD EVP, Medical and Scientific Affairs

1

Building on the Zimbabwe Experience to Achieve Global Elimination

of New HIV Infections in Children

Nick Hellmann, MDEVP, Medical and Scientific Affairs

Page 2: Nick Hellmann, MD EVP, Medical and Scientific Affairs

Global Impact of HIV/AIDS on Children

Pediatric HIV/AIDS Global Estimate2011 (% of total*)

Children living with HIV/AIDS 3.4 million (10%)

New HIV Infections in children 330,000 (13%)

Deaths in children with HIV/AIDS

230,000 (14%)

Together We Will End AIDS (UNAIDS, July 2012)

* Denominators for percentage calculations are global adult+children estimates

Page 3: Nick Hellmann, MD EVP, Medical and Scientific Affairs

Global Plan for elimination of new HIV

infections in children and keeping their mothers alive

2011-2015 Goals Goal 1: >90% reduction in new HIV infections in children Goal 2: >50% reduction in AIDS- related maternal/child deaths

Launched at UN General Assembly

Special Session, June 2011

Page 4: Nick Hellmann, MD EVP, Medical and Scientific Affairs

India

SouthAfrica

Uganda

Kenya

D.R. Congo

Malawi

Tanzania

Zambia

Zimbabwe

Swaziland

Cameroon

Mozambique

Cote d’Ivoire

Lesotho

Ethiopia

Angola

Botswana

Chad

Nigeria

Ghana

Global Plan: 22 Priority Countries

Burundi

Namibia

Page 5: Nick Hellmann, MD EVP, Medical and Scientific Affairs

India Rwanda

SouthAfrica

Uganda

Kenya

D.R. Congo

Malawi

Tanzania

Zambia

Zimbabwe

Swaziland

Cameroon

Mozambique

Cote d’Ivoire

Lesotho

Ethiopia

Angola

Botswana

Chad

Nigeria

Ghana

Burundi

Namibia

EGPAF INTERNATIONAL PROGRAMS: 2011 5,932 SITES IN 15 COUNTRIES

Page 6: Nick Hellmann, MD EVP, Medical and Scientific Affairs

EGPAF Strategy: ThreeIntegrated Areas of Focus

6

Global Program Implementation

Global Advocacy

Global Research

Page 7: Nick Hellmann, MD EVP, Medical and Scientific Affairs

PMTCT

STRATEGIES FOR ELIMINATING HIV/AIDS IN CHILDREN

WomenBecome HIV-positive

Stay HIV-negative1

Pregnant

Not intending pregnancy Not pregnant2

Slide 7

Prevent HIV infection in women

Prevent unintended pregnancies in HIV+ women

Prevent mother-to-child HIV transmission

Infectedinfants

4

Early diagnosis,care and ART,

supportHIV testingARV drugs

Infant feeding3 Uninfected

infants

Page 8: Nick Hellmann, MD EVP, Medical and Scientific Affairs

Country Program Approach

• Strategic partnering– Government, implementing partners, community

• Increase access to PMTCT/Care &Treatment– Integrated within public facilities and MCH/RH services

• Optimize program services/interventions– Increase quality, innovation, monitoring, evaluation to

improve effectiveness and efficiency of services

• Strengthen health systems– Capacity building for local ownership and sustainability

• Address policy and advocacy gaps– Eg, national strategies/guidelines, task shifting/sharing

• Engage and support community– Drive service demand, uptake, adherence, retention

Page 9: Nick Hellmann, MD EVP, Medical and Scientific Affairs

EGPAF International Programs2000 – 2011*

• PMTCT access – EGPAF-supported sites– Reached 14.2 million pregnant women

(nearly 2.5 million in 2011)– Accounted for nearly 20% of pregnant women

who received ARV for prophylaxis in low/middle income countries in 2010

• Care and Treatment – EGPAF-supported sites– Enrolled 1,600,000 in HIV care programs– Initiated antiretroviral treatment (ART) in

860,000 adults & children*EGPAF data through Dec 2011

Page 10: Nick Hellmann, MD EVP, Medical and Scientific Affairs

10

PMTCT Cascade Challenges

Antenatal clinic

Counseling and testing

Receive test results

HIV Infection

No infection

PMTCT services/drugs,

CD4 test,ART,

partner testing

Prevention services

Delivery inhealth facility

Infant PMTCT drugs, breastfeeding support,

family planning, infant HIV diagnosis/ART

Page 11: Nick Hellmann, MD EVP, Medical and Scientific Affairs

Attend ANC 92%

Counseled and tested for HIV

80%

Get ARVs (pre- and perinatal)

70%

100 HIV+ mothers

92

74

52

Enrolled in PMTCT

program

8

26

48

Lost from PMTCT

program

PMTCT: Most Critical Determinant of Effectiveness is Number of Women Completing PMTCT Cascade

Modified from P. Barker:WHO Mtg Nov 2008

Infants infected 1 – 3 12 13 – 15

TOTAL

Common cascadeefficiency

(80-90%)

Page 12: Nick Hellmann, MD EVP, Medical and Scientific Affairs

LOSS-TO-FOLLOW-UP ON ART (SOUTH AFRICA)Trend consistent across all sites

0.00

0.05

0.10

0.15

0.20

0.25

0 1 2 3 4 5 6 7 8 9 10 11 12Months after ART initiation

Not pregnant Pregnant

Kaplan-Meier failure estimates: LTFU after ART initiation

p<0.001

L Myer, et al: Loss to follow-up and mortality among pregnant and non-pregnant women initiating ART across South Africa. CROI - Seattle Mar 2012

LTFU by 12 months after ART initiation among women:

• 19% if pregnant• 11% if not

pregnant

(N=29,653 women initiating ART at6 sites in Johannesburg, Cape Town, Durban, and Hlabisa from 2002-9)

Page 13: Nick Hellmann, MD EVP, Medical and Scientific Affairs

WHO 2010 PMTCT Guideline Scale-up:EGPAF/Kapnek/OPHID/ZAPP approach

Partner-supported PMTCT sites of na-

tional total

Sites providing WHO 2010 PMTCT

services

Eligible HIV+ pregnant women

on ART

0%

20%

40%

60%

80%

100%

52%

9%17%

86%

99%

37%

End 2010 End 2011

2011: 1344 program-supported sites enrolled nearly 370,000 pregnant women

Key 2011 interventions:• National training• Supportive supervision• District-level managers• POC CD4 testing• ART initiation in ANC• Community engagement

Page 14: Nick Hellmann, MD EVP, Medical and Scientific Affairs

GLOBAL HIV/AIDS RESPONSE: Progress Report 2011

Page 15: Nick Hellmann, MD EVP, Medical and Scientific Affairs

A progress report on the Global Plan, 2012

New HIV infections among children (0-14 years old):2001-2011 and target for 2015

Global eliminationof pediatric HIV/AIDS

can be achieved!

Page 16: Nick Hellmann, MD EVP, Medical and Scientific Affairs

Thank you!